Shilpa Medicare Limited Share Price & Analysis

Shilpa Medicare reports Q1FY26 financial results

*Shilpa Medicare reports Q1FY26 financial results* from its board meeting. The company announced consolidated financial results for the quarter ended June 30, 2026. Key figures include revenue of **₹127.4 crore** and net profit of **₹18.2 crore**, up **14% YoY**. Performance reflects sustained growth in API and formulations segments. 📊 *STOCKS:* $SHILPAMED | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings

Shilpa Medicare Bengaluru unit fails USFDA inspection

*Shilpa Medicare Bengaluru unit fails USFDA inspection* — The company's Bengaluru facility has received **5 observations** following a USFDA pre-approval inspection (PAI), signaling potential delays in product approvals. This regulatory setback could impact export plans and investor sentiment. Immediate corrective actions may be required to address compliance issues. 📊 *STOCKS:* SHILPAM | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #USFDA

Shilpa Medicare's Ondansetron injection gets SEC final approval

*Shilpa Medicare's Ondansetron injection gets SEC final approval*. The company’s novel OERIS (Ondansetron Extended-Release Injection, **100 mg/mL**) has received final approval from the Subject Expert Committee for marketing authorization. This clears a key regulatory hurdle for commercialization in India. Approval boosts prospects for revenue from complex generics in the injectables segment. 📊 *STOCKS:* $SHILPAM | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Pharma

Shilpa Biologicals signs co-development deal with Finland's Orion

*Shilpa Biologicals signs co-development deal with Finland's Orion* Shilpa Biologicals Pvt Ltd, a wholly owned subsidiary of Shilpa Medicare, has entered into a co-development and supply agreement with Orion Corporation of Finland. The partnership focuses on advancing and supplying pharmaceutical products. This strategic move enhances Shilpa's global footprint and R&D capabilities. 📊 *STOCKS:* SHILPAMED | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #pharma

Shilpa Medicare commissions ADC manufacturing facility via subsidiary

*Shilpa Medicare commissions ADC manufacturing facility via subsidiary*. A state-of-the-art GMP facility for Antibody Drug Conjugates has been commissioned by Shilpa Biologicals, a material subsidiary. This marks a strategic expansion into high-value biopharma products. The move strengthens its footprint in the global specialty pharmaceuticals market. 📊 *STOCKS:* SHILPAMED | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #ADC

Shilpa Medicare assigned ESG rating by CRISIL

*Shilpa Medicare assigned ESG rating by CRISIL* CRISIL ESG Ratings has assigned an ESG score to Shilpa Medicare, marking a step in sustainability disclosure. While the rating reflects improved transparency, it does not imply immediate financial impact. The move may support long-term investor sentiment. 📊 *STOCKS:* $SHILPAMED | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ESG

Shilpa Medicare to hold investor meet

*Shilpa Medicare to hold investor meet* to discuss business updates and strategy. The event is scheduled as part of its investor engagement calendar. No financial numbers or guidance were disclosed. It offers a platform for institutional investors to interact with management. 📊 *STOCKS:* $SHILPAMED | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet

Shilpa Medicare to hold shareholder meeting on Sept 11, 2026

*Shilpa Medicare to hold shareholder meeting on Sept 11, 2026.* The event is a routine corporate disclosure with no immediate financial implications. Details of agenda items are not specified in the filing. Such meetings typically cover statutory approvals or board matters. 📊 *STOCKS:* $SHILPAM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholderMeeting

Shilpa Medicare shares to watch after investor presentation

*Shilpa Medicare shares to watch after investor presentation.* The company shared an investor presentation through a BSE filing, highlighting business updates and strategy. No major financial figures or announcements were disclosed. Traders may assess visuals and commentary for sentiment cues. 📊 *STOCKS:* $SHILPAMED | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorPresentation

Shilpa Medicare sets dividend record date

*Shilpa Medicare sets dividend record date* for **04-Sep-2026**, marking the cutoff for shareholder eligibility. The company has informed the NSE about the record date for dividend distribution. No dividend amount or payment date has been disclosed yet. Investors must hold shares by the record date to qualify. 📊 *STOCKS:* $SHILPAMED | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dividend